M&A Activity • Dec 6, 2023
M&A Activity
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9412V
Compagnie de Saint-Gobain
06 December 2023
SAINT-GOBAIN has REACHED AN AGREEMENT for the sale of ITS PIR INSULATION ACTIVITY IN THE UK
Saint-Gobain has reached an agreement with SOPREMA for the sale of a majority stake in its polyisocyanurate insulation (PIR) activity in the United Kingdom under the Celotex brand.
This transaction enables Saint-Gobain to continue refining its portfolio and focus its efforts in a manner that best serves its customers. SOPREMA, which already manufactures and sells PIR insulation across Europe, will be best positioned to support the Celotex business in its next stage of growth.
Celotex operates two manufacturing facilities in Hadleigh, Suffolk and Eggborough, Yorkshire and employs 155 people.
The completion of the transaction is expected to be finalized in early 2024.
Celotex's assets will be transferred to a new standalone company, which will be 75% owned by SOPREMA once the transaction is complete. Saint-Gobain will retain a 25% minority stake in this new company for the time needed to ensure a smooth transition.
This transaction is part of Saint-Gobain's continued business profile optimization strategy, in line with the "Grow & Impact" strategic plan.
| Analyst/investor relations | Press relations | ||
| Vivien Dardel: | +33 1 88 54 29 77 | Patricia Marie : | +33 1 88 54 26 83 |
| Floriana Michalowska: | +33 1 88 54 19 09 | Laure Bencheikh : | +33 1 88 54 26 38 |
| Alix Sicaud: | +33 1 88 54 38 70 | Flavio Bornancin-Tomasella : | +33 1 88 54 27 96 |
| James Weston: | +33 1 88 54 01 24 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DISGZMGZRVZGFZM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.